Linde (LIN) is back in focus after William O'Neil initiated coverage, highlighting its strong market position, a reported US$10b project backlog, and ties to areas like clean hydrogen and semiconductor manufacturing.
See our latest analysis for Linde.
The recent 13.92% 90-day share price return and 21.27% 1-year total shareholder return suggest momentum has been building, as investors respond to Linde’s new US facility plans and the announcement of first quarter 2026 results.
If you are looking beyond industrial gases and want to see what else is gaining attention around infrastructure and next generation power, take a look at 28 power grid technology and infrastructure stocks
With Linde shares around US$494.59 and trading only slightly below the average analyst price target of about US$513.85, the key question now is whether there is still a buying opportunity here or if the market is already pricing in future growth.
Most Popular Narrative: 1.8% Undervalued
Linde’s most followed narrative places fair value at about $503.52, just above the recent $494.59 close. This frames a tight valuation gap supported by long-term project assumptions.
Linde's ongoing focus on digitalization, operational optimization, and network density, including base volume growth CapEx and bolt-on M&A, should continue to drive self-help margin improvement and support strong operating cash flow and net margin expansion, even through cyclical downturns.
Read the complete narrative. Read the complete narrative.
Want to see what sits behind that margin story and fair value? The narrative leans heavily on projected earnings, cash generation, and a richer profit profile. The exact mix of growth, buybacks, and profitability assumptions might surprise you.
Result: Fair Value of $503.52 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this depends on industrial demand remaining stable. Prolonged weakness in Europe or a slower than expected rollout of clean energy could quickly challenge that fair value story.
Find out about the key risks to this Linde narrative.
Another Way To Look At Value
That 1.8% undervaluation story sits awkwardly next to Linde’s current P/E of 33.2x, which is above both its fair ratio of 27.8x and the US Chemicals industry at 28.2x. If the market moves closer to that fair ratio, how comfortable are you with the valuation risk baked in today?
See what the numbers say about this price in our valuation breakdown See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If this mix of optimism and concern feels finely balanced, now is the time to look through the data yourself and pressure test the assumptions. To see both sides laid out clearly, review the 2 key rewards and 2 important warning signs
Looking for more investment ideas?
If you stop your research with Linde, you could miss other opportunities that match your goals, risk comfort, and income needs across different types of companies.
- Target value opportunities that combine quality and attractive pricing by checking the 61 high quality undervalued stocks.
- Strengthen your potential income stream by reviewing the 13 dividend fortresses.
- Prioritise resilience and capital protection by scanning the 70 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com